Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
980.8 INR | +1.30% | -1.59% | +42.42% |
May. 09 | Zydus Lifesciences Gets US FDA Final Nod for Acne Treatment Gel | MT |
May. 09 | Zydus Lifesciences Limited Receives Final Approval from USFDA for Dapsone Gel, 7.5% | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.42% | 11.67B | |
+20.43% | 42.97B | |
+24.11% | 22.49B | |
+16.41% | 14.93B | |
+9.84% | 13.14B | |
-9.16% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.54B | |
+9.14% | 4.86B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- News Zydus Lifesciences Limited
- Zydus Lifesciences' Desidustat Tablets Get Nod from China Regulator